|
Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication
RECRUITINGSponsored by Copenhagen University Hospital at Herlev
Actively Recruiting
SponsorCopenhagen University Hospital at Herlev
Started2017-08-01
Est. completion2025-12-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04741906
Summary
Aim of the study is to examine the feasibility of dental implant insertion in patients receiving high, adjuvant and low dose \> 4 years.
Eligibility
Healthy volunteers accepted
Inclusion Criteria: * Patient with cancer or osteoporosis, treated with antiresorptive treatment. * The patients should have sufficient compliance, this includes willingness to have the planned assessments * The patient should have an expected life span at enrollment of at least 2 years. * The local bone quality and quantity should be sufficient for implant insertion without bone augmentation and is classified according to the classification by Cawood \& Howell 1988. Exclusion Criteria: * \> 10 cigarettes daily * HbA1c \> 53 mmol/mol * Poor oral hygiene * Poor general condition: ECOG score 3 or 4. * Poor prognosis: Expected survival \<2 year is an exclusion cause. * Presence of metastases of the liver brain. * Poor local jaw bone quality acc. to Cawood classification stage 3 or 4. * Unwillingness to comply with the planned assessments and recordings
Conditions4
CancerImplantsMissing TeethOsteoporosis
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorCopenhagen University Hospital at Herlev
Started2017-08-01
Est. completion2025-12-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04741906